Diagnostic test to help you find the most suitable cancer treatment.
Cancer is caused by alterations in the DNA, known as mutations, which cause cells to multiply and grow uncontrollably. While this is true for all cancer types, the differences in these mutations give each cancer its own identity. Understanding the genomic characteristics of individual tumours opens up the option for personalised targeted treatments.
To help patients find the most appropriate treatment options, Diagnose.me provides a comprehensive diagnostic test that examines the genetic structure of tumour cells. The test results identify the most effective and ineffective therapies and treatment plans based on the specific genomic profile of any given tumour. Collaboration with the patient’s treating oncologist is essential.
In addition to traditional chemotherapies, there are hundreds of targeted therapies already in clinical use (and many more in clinical development). However, the genomic tests that identify them are not yet commonly available in public healthcare. Diagnose.me aims to provide access to such tests to anyone who might need them, especially when the traditional approach fails.
Patients receive a list of approved therapies and effective registered drugs for their specific genetic mutation (depending on the country, 30-100% of recommended therapies are commonly available). Given the wide range of possible genetic mutations, patients also receive recommendations for potentially effective therapies and available clinical trials, which broadens the scope of treatment possibilities. This approach minimises harm to healthy cells and enhances the effectiveness of the treatment while reducing its side effects.
The Personalised oncology service is designed to assist patients who have received a cancer diagnosis and are actively seeking personalised and targeted therapy options. Eligible patients need to provide a tissue or blood sample for analysis. Patients unsure about their eligibility can contact our support team for guidance.
The Personalised Oncology service is carried out by our certified scientific providers, Foundation Medicine, Inc. (Roche Holding AG), Oncompass Medicine and MultiplexDX, Inc. Together with your oncologist we help you to choose the one that best suits your needs.
After consulting your oncologist, you will have the support of our team to choose the most suitable provider.
Fill out an order form with relevant information and details about your medical history.
Your pathology lab sends an existing tissue or blood sample to one of the provider's laboratories.
The sample undergoes in-depth analysis of its genetic and molecular features.
A comprehensive report with identified genetic alterations and personalised treatement options is provided.
The content of the report may vary for each patient based on individual findings. Available treatment options are contingent on the patient's geographical location.
Clients of one of our partner companies have the exclusive opportunity to access the Personalised oncology service completely free of charge. Verify whether you are entitled to this benefit.
Independent patients can take control of their cancer journey and order the Personalised oncology service right away.
from 4 900 €
Are you keen on providing cutting-edge health care solutions to your employees or clients? Contact us to discuss the possibilities.
Gerente de Desarrollo de Negocios
kevin.karabin@diagnose.me
Diagnose.me